Human T-Lymphotrophic Viruses and Diseases of Long Latency

Editorials1 July 1989Human T-Lymphotrophic Viruses and Diseases of Long LatencyWilliam A. Blattner, MDWilliam A. Blattner, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-111-1-4 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn 1980 the report of the discovery of the first human retrovirus, human T-lymphotrophic virus type I (HTLV-I) (1), culminated a search for such an agent that started at the beginning of the 20th century. This discovery was overshadowed by the acquired immunodeficiency syndrome (AIDS) epidemic, while paradoxically providing the fundamental biologic insights critical for discovering the cause of AIDS (2, 3). Although the secrets of HTLV-I have been unlocked more slowly than those of human immunodeficiency virus (HIV), which causes AIDS, HTLV-I has provided insights into several human diseases. For example, HTLV-I is associated with a form of malignancy,...References1. PoieszRuscettiGazdarBunnMinnaGallo BFAPJR. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9. CrossrefMedlineGoogle Scholar2. Barre-SinoussiChermannRey FJF. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-71. CrossrefMedlineGoogle Scholar3. GalloSalahuddinPopovic RSM. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224:500-3. CrossrefMedlineGoogle Scholar4. Statistical analyses of clinicopathological, virological and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. The T- and B-cell Malignancy Study Group. Jpn J Clin Oncol. 1985;15:517-35. CrossrefMedlineGoogle Scholar5. BlattnerKalyanaramanRobert-Guroff WVM. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer. 1982;30:257-64. CrossrefMedlineGoogle Scholar6. GessainBarinVernant AFJ. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407-10. CrossrefMedlineGoogle Scholar7. Rodgers-JohnsonMorganMora POC. The role of HTLV-I in tropical spastic paraparesis in Jamaica. Ann Neurol. 1988;23 (Suppl):S121-6. CrossrefMedlineGoogle Scholar8. OcameMatsumotoUsuku MMK. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotrophic virus type I and adult T-cell leukemia-like cells. Ann Neurol. 1987;21:117-22. CrossrefMedlineGoogle Scholar9. ReddySandberg-WollheimMettusRayDeFreitasKoprowski EMRPEH. Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients. Science. 1989;243:529-33. CrossrefMedlineGoogle Scholar10. GreenbergEhrlichAbbottHurwitzWaldmannPoiesz SGMBTB. Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification. Proc Natl Acad Sci USA. 1989;86:2878-82. CrossrefMedlineGoogle Scholar11. UchiyamaYodoiSagawaTakatsukiUchino TJKKH. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-92. CrossrefMedlineGoogle Scholar12. JaffeBlattnerBlayney EWD. The pathologic spectrum of HTLV-associated leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol. 1984;8:263-75. CrossrefMedlineGoogle Scholar13. YamaguchiNishimuraKawano KHF. A proposal for smoldering adult T-cell leukemia—diversity in clinical pictures of adult T-cell leukemia. Jpn J Clin Oncol. 1983;13:189-99. MedlineGoogle Scholar14. GibbsLoftersCampbell WWM. Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell-lymphoma. Ann Intern Med. 1987;106:361-8. LinkGoogle Scholar15. BunnSchechterJaffe PGE. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983;309:257-64. CrossrefMedlineGoogle Scholar16. BlattnerGibbsSaxinger WWC. Human T-cell leukaemia/lymphoma virus-associated lymphoreticular neoplasia in Jamaica. Lancet. 1983;2:61-4. CrossrefMedlineGoogle Scholar17. MurphyHanchardFigueroa EBJ. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250-3. CrossrefMedlineGoogle Scholar18. GalloKalyanaramanSarngadharan RVM. Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res. 1983;43:3892-9. MedlineGoogle Scholar19. DugganEhrlichDavey DGF. HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA. Blood. 1988;71:1027-32. CrossrefMedlineGoogle Scholar20. MannDeSantisMark DPG. HTLV-I-associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science. 1987;236:1103-6. CrossrefMedlineGoogle Scholar21. MatsuoNakamuraTsujihata HTM. Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy. Lancet. 1988;2:1109-13. CrossrefMedlineGoogle Scholar22. MurphyGibbsFigueroa EWJ. Sexual transmission of HTLV-I in an endemic area. In: Proceedings IV International Conference on AIDS, Book 2: Abstract No. 4659 (1988). Google Scholar23. Blattner W. Retroviruses. In: Evans AS, ed. Viral Infections of Humans: Epidemiology and Control. 3d ed. New York: Plenum Medical Book Co.; 1989:545-92. CrossrefGoogle Scholar24. UsukuSonodaOsame KSM. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol. 1988;23(Suppl):S143-50. CrossrefMedlineGoogle Scholar25. Robert-GuroffWeissGiron MSJ. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986;255:3133-7. CrossrefMedlineGoogle Scholar26. KalyanaramanSarngadharanRobert-GuroffMiyoshiGoldeGallo VMMIDR. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982;218:571-3. CrossrefMedlineGoogle Scholar27. WilliamsFangSlamon ACD. Seroprevalence and epidemiologic correlates of HTLV-I infection in U.S. blood donors. Science. 1988;240:643-6. CrossrefMedlineGoogle Scholar28. LeeSwansonShorty HPV. High rate of HTVL-II infection in seropositive IV drug abusers in New Orleans. Science. 1989;244:471-5. CrossrefMedlineGoogle Scholar29. . Licensure of screening tests for antibody to human T-lymphotropic virus type I. MMWR. 1988;37:736-47. MedlineGoogle Scholar30. Gallo R. The first human retrovirus. Sci Am. 1986;255:88-98. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: William A. Blattner, MD PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheepVestibular-Evoked Myogenic Potential (VEMP) to Evaluate Cervical Myelopathy in Human T-Cell Lymphotropic Virus Type I InfectionThe Human/Animal Interface: Emergence and Resurgence of Zoonotic Infectious DiseasesEndemic versus epidemic viral spreads display distinct patterns of HTLV-2b replicationVirology ResearchHigh Prevalence of HTLV-I and HTLV-II among Blood Donors in Argentina: A South American Health ConcernHuman T-lymphotropic virus type I/II infections in volunteer blood donors from Northern and Western Greece: increased prevalence in one blood bank unitLaboratory Detection of Human Retroviral InfectionHigh simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeysA Cluster of Human T-Cell Lymphotropic Virus Type I–Associated Myelopathy/Tropical Spastic Paraparesis in Jujuy, ArgentinaMolecular and cellular aspects of HTLV-1 associated leukemogenesis in vivoSimultaneous Occurrence of HTLV-I Associated Myelopathy, Uveitis and Smouldering Adult T Cell LeukaemiaImplication of HTLV-I Infection, Strongyloidiasis, and P53 Overexpression in the Development, Response to Treatment, and Evolution of Non-Hodgkin's Lymphomas in an Endemic Area (Martinique, French West Indies)Human T-Cell Lymphotropic Virus Type 1 Tax among American Blood DonorsRelationship between Anti-Tax Antibody Responses and Cocultivatable Virus in HTLV-I-Infected RabbitsCellular Latency in HIV-1 InfectionSimian T-Lymphotropic Virus Type IActivation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factorMedical Section of the American Lung Association: Control of Tuberculosis in the United StatesDIAGNOSIS AND TREATMENT OF SUBSTANCE USERS WITH HIV INFECTIONImmune function and anti-HTLV-I/II status in anti-HIV-1 -negative intravenous drug users receiving methadoneThe epidemiology of HTLV-I infectionImmune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadoneLepromatous leprosy and seropositivity for HTLV-IHTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug usersViruses and cancer of the immune system 1 July 1989Volume 111, Issue 1Page: 4-6KeywordsAIDSBiologicsHIVRetroviruses ePublished: 1 December 2008 Issue Published: 1 July 1989 PDF downloadLoading ...